232 related articles for article (PubMed ID: 23403252)
61. Frequency of WT1 and 11p15 constitutional aberrations and phenotypic correlation in childhood Wilms tumour patients.
Segers H; Kersseboom R; Alders M; Pieters R; Wagner A; van den Heuvel-Eibrink MM
Eur J Cancer; 2012 Nov; 48(17):3249-56. PubMed ID: 22796116
[TBL] [Abstract][Full Text] [Related]
62. A high incidence of WT1 abnormality in bilateral Wilms tumours in Japan, and the penetrance rates in children with WT1 germline mutation.
Kaneko Y; Okita H; Haruta M; Arai Y; Oue T; Tanaka Y; Horie H; Hinotsu S; Koshinaga T; Yoneda A; Ohtsuka Y; Taguchi T; Fukuzawa M
Br J Cancer; 2015 Mar; 112(6):1121-33. PubMed ID: 25688735
[TBL] [Abstract][Full Text] [Related]
63. Evaluation of chromosome 11p imbalances in aniridia and Wilms tumor patients.
Busch M; Leube B; Thiel A; Schanze I; Beier M; Royer-Pokora B
Am J Med Genet A; 2013 May; 161A(5):958-64. PubMed ID: 23494989
[TBL] [Abstract][Full Text] [Related]
64. Bilateral Wilms' tumor in a child with Denys-Drash syndrome: novel frameshift variant disrupts the WT1 nuclear location signaling region.
Guaragna MS; Ledesma FL; Manzano VZ; Maciel-Guerra AT; Guerra-Júnior G; Silva MM; Luiz de Brito P; Palandi de Mello M
J Pediatr Endocrinol Metab; 2022 Jun; 35(6):837-843. PubMed ID: 35304980
[TBL] [Abstract][Full Text] [Related]
65. Genotype/phenotype correlation in nephrotic syndrome caused by WT1 mutations.
Chernin G; Vega-Warner V; Schoeb DS; Heeringa SF; Ovunc B; Saisawat P; Cleper R; Ozaltin F; Hildebrandt F;
Clin J Am Soc Nephrol; 2010 Sep; 5(9):1655-62. PubMed ID: 20595692
[TBL] [Abstract][Full Text] [Related]
66. Frequent association of beta-catenin and WT1 mutations in Wilms tumors.
Maiti S; Alam R; Amos CI; Huff V
Cancer Res; 2000 Nov; 60(22):6288-92. PubMed ID: 11103785
[TBL] [Abstract][Full Text] [Related]
67. Convergent evolution of 11p allelic loss in multifocal Wilms tumors arising in WT1 mutation carriers.
Valind A; Wessman S; Pal N; Karlsson J; Jonson T; Sandstedt B; Gisselsson D
Pediatr Blood Cancer; 2018 Nov; 65(11):e27301. PubMed ID: 29968962
[TBL] [Abstract][Full Text] [Related]
68. Molecular and epidemiologic characterization of Wilms tumor from Baghdad, Iraq.
Phelps HM; Al-Jadiry MF; Corbitt NM; Pierce JM; Li B; Wei Q; Flores RR; Correa H; Uccini S; Frangoul H; Alsaadawi AR; Al-Badri SAF; Al-Darraji AF; Al-Saeed RM; Al-Hadad SA; Lovvorn Iii HN
World J Pediatr; 2018 Dec; 14(6):585-593. PubMed ID: 30155617
[TBL] [Abstract][Full Text] [Related]
69. Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children's Oncology Group Study.
Gadd S; Huff V; Huang CC; Ruteshouser EC; Dome JS; Grundy PE; Breslow N; Jennings L; Green DM; Beckwith JB; Perlman EJ
Neoplasia; 2012 Aug; 14(8):742-56. PubMed ID: 22952427
[TBL] [Abstract][Full Text] [Related]
70. Constitutional mutations in the WT1 gene in patients with Denys-Drash syndrome.
Baird PN; Santos A; Groves N; Jadresic L; Cowell JK
Hum Mol Genet; 1992 Aug; 1(5):301-5. PubMed ID: 1338906
[TBL] [Abstract][Full Text] [Related]
71. Different incidences of epigenetic but not genetic abnormalities between Wilms tumors in Japanese and Caucasian children.
Haruta M; Arai Y; Watanabe N; Fujiwara Y; Honda S; Ohshima J; Kasai F; Nakadate H; Horie H; Okita H; Hata J; Fukuzawa M; Kaneko Y
Cancer Sci; 2012 Jun; 103(6):1129-35. PubMed ID: 22409817
[TBL] [Abstract][Full Text] [Related]
72. Description of mutation spectrum and polymorphism of Wilms' tumor 1 (WT1) gene in hypospadias patients in the Indonesian population.
Diposarosa R; Pamungkas KO; Sribudiani Y; Herman H; Suciati LP; Rahayu NS; Effendy SH
J Pediatr Urol; 2018 Jun; 14(3):237.e1-237.e7. PubMed ID: 29958641
[TBL] [Abstract][Full Text] [Related]
73. Frequent hypermethylation of a CTCF binding site influences Wilms tumor 1 expression in Wilms tumors.
Zitzmann F; Mayr D; Berger M; Stehr M; von Schweinitz D; Kappler R; Hubertus J
Oncol Rep; 2014 Apr; 31(4):1871-6. PubMed ID: 24534946
[TBL] [Abstract][Full Text] [Related]
74. A novel Wilms' tumor 1 gene mutation in a child with severe renal dysfunction and persistent renal blastema.
Wagner N; Wagner KD; Afanetti M; Nevo F; Antignac C; Michiels JF; Schedl A; Berard E
Pediatr Nephrol; 2008 Sep; 23(9):1445-53. PubMed ID: 18516627
[TBL] [Abstract][Full Text] [Related]
75. The Wilms tumour gene, WT1, in normal and abnormal nephrogenesis.
Pritchard-Jones K
Pediatr Nephrol; 1999 Sep; 13(7):620-5. PubMed ID: 10460515
[TBL] [Abstract][Full Text] [Related]
76. Association of TP53 polymorphisms on the risk of Wilms tumor.
Andrade RC; Cardoso LC; Ferman SE; Faria PS; Seuánez HN; Achatz MI; Vargas FR
Pediatr Blood Cancer; 2014 Mar; 61(3):436-41. PubMed ID: 24038938
[TBL] [Abstract][Full Text] [Related]
77. WT1 Haploinsufficiency Supports Milder Renal Manifestation in Two Patients with Denys-Drash Syndrome.
Guaragna MS; Ribeiro de Andrade JG; de Freitas Carli B; Belangero VM; Maciel-Guerra AT; Guerra-Júnior G; de Mello MP
Sex Dev; 2017; 11(1):34-39. PubMed ID: 28081536
[TBL] [Abstract][Full Text] [Related]
78. Wilms tumor genes.
Huff V; Saunders GF
Biochim Biophys Acta; 1993 Dec; 1155(3):295-306. PubMed ID: 8268188
[TBL] [Abstract][Full Text] [Related]
79. Significant reduction of WT1 gene expression, possibly due to epigenetic alteration in Wilms' tumor.
Satoh Y; Nakagawachi T; Nakadate H; Kaneko Y; Masaki Z; Mukai T; Soejima H
J Biochem; 2003 Mar; 133(3):303-8. PubMed ID: 12761165
[TBL] [Abstract][Full Text] [Related]
80. Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology.
Schumacher V; Schneider S; Figge A; Wildhardt G; Harms D; Schmidt D; Weirich A; Ludwig R; Royer-Pokora B
Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3972-7. PubMed ID: 9108089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
